Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENZALUTAMIDE vs NILUTAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENZALUTAMIDE vs NILUTAMIDE: Safety Overview

Metric ENZALUTAMIDE NILUTAMIDE
Total FAERS Reports 49,270 62
Deaths Reported 9,676 6
Death Rate 19.6% 9.7%
Hospitalizations 9,282 9
Average Patient Age 76.0 yrs 77.1 yrs
% Female Patients 0.6% 0.0%
FDA Approval Date Apr 22, 2022 Apr 30, 1999
Manufacturer Astellas Pharma US, Inc. Prasco Laboratories
Route ORAL ORAL
Marketing Status Prescription Discontinued